My Watchlist Items

      No Watchlist
Array ( [0] => stdClass Object ( [symbol] => RSLS [price] => 5.5 [beta] => 1.710695 [volAvg] => 573 [mktCap] => 33916024 [lastDiv] => 0 [range] => 1.14-14.0 [changes] => 0 [companyName] => ReShape Lifesciences Inc. [currency] => USD [cik] => 0001371217 [isin] => US7611236032 [cusip] => 761123603 [exchange] => Nasdaq Capital Market [exchangeShortName] => NASDAQ [industry] => Medical Devices [website] => http://www.reshapelifesciences.com [description] => ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in morbidly obese patients without permanently cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California. [ceo] => Mr. Barton Bandy [sector] => Healthcare [country] => US [fullTimeEmployees] => 37 [phone] => 19494296680 [address] => 1001 Calle Amanecer [city] => San Clemente [state] => CALIFORNIA [zip] => 92673 [dcfDiff] => -0.25 [dcf] => 5.96158 [image] => https://financialmodelingprep.com/image-stock/RSLS.jpg [ipoDate] => 2007-11-15 [defaultImage] => 1 [isEtf] => [isActivelyTrading] => 1 ) )
ReShape Lifesciences Inc. (RSLS)
   5.5   0(0%)
ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in morbidly obese patients without permanently cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.
TitleNamePayCurrency PayGenderYear BornTitle Since
Vice President of Fin. & Corporation Controller Mr. Brendan O'Connell N/A USD male N/A N/A
Senior Vice President of Commercial Mr. Kevin Condrin N/A USD male N/A N/A
Director of Communications Jody B. Dahlman N/A USD N/A N/A
Vice President of Regulatory & Clinical Affairs and Compliance Officer Dr. Dov Gal N/A USD N/A N/A
Chief Technology Officer & Bus. Devel. Dr. Rajesh Nihalani N/A USD N/A N/A
Senior Vice President of Operations and R&D Mr. Vipul Shah N/A USD male N/A N/A
Co-Founder Dr. Katherine S. Tweden N/A USD N/A N/A
Co-Founder and Special Advisor to the Chief Executive Officer Dr. Mark B. Knudson Ph.D. N/A USD N/A N/A
Senior Vice President of Fin. & Chief Financial Officer Mr. Thomas Stankovich 290000 USD male 1961 N/A
Pres, Chief Executive Officer & Director Mr. Barton P. Bandy 377000 USD male 1963 N/A
SymbolDateRatingRating Score Rating Details
RSLS 11 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
RSLS 10 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 9 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 8 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 7 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 4 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 3 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 2 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 1 June, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 28 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 27 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 26 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 25 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 24 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 21 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 20 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 19 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 18 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 17 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 14 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 13 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 12 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 11 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 10 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 7 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 6 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 5 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 4 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 3 May, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 30 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 29 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 28 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 27 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 26 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 23 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 22 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 21 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 20 April, 2021 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 31 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Neutral)
RSLS 28 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 27 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 26 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 24 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 21 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 20 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 19 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 18 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 17 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 14 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 13 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 12 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 11 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 10 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 7 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 6 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 4 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 3 December, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 30 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 29 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 28 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 27 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 26 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 23 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 21 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 20 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 19 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 16 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 15 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 14 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 13 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 12 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 9 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 8 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 7 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 6 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 5 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 2 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 1 November, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 31 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 30 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 29 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 26 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 25 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 24 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 23 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 22 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 19 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 18 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 17 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 16 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 15 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 12 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 11 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 10 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 9 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 8 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 5 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 4 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 3 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
RSLS 2 October, 2018 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
Armistice Capital LLC 215666 20 August, 2020 3998
Heights Capital Management, Inc. 10233 31 December, 2019 7064
District 2 Capital LP 20588 27 September, 2019 7843
Bigger Capital Funds, LP 14412 27 September, 2019 5490
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
RSLS 4 December, 2020 0001601086 5330277 0001371217 ARMISTICE CAPITAL, LLC A 4 5400 Common Stock View
RSLS 2 December, 2020 0001601086 5324877 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 17 November, 2020 0001601086 5323877 0001371217 ARMISTICE CAPITAL, LLC A 4 187 Common Stock View
RSLS 13 November, 2020 0001601086 5323690 0001371217 ARMISTICE CAPITAL, LLC A 4 790 Common Stock View
RSLS 10 November, 2020 0001601086 5322900 0001371217 ARMISTICE CAPITAL, LLC A 4 2400 Common Stock View
RSLS 2 November, 2020 0001601086 5320500 0001371217 ARMISTICE CAPITAL, LLC A 4 3100 Common Stock View
RSLS 23 September, 2020 0001601086 5317400 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 23 September, 2020 0001601086 5316400 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 22 September, 2020 0001601086 5315400 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 21 September, 2020 0001601086 5314400 0001371217 ARMISTICE CAPITAL, LLC A 4 300 Common Stock View
RSLS 18 September, 2020 0001601086 5314100 0001371217 ARMISTICE CAPITAL, LLC A 4 2000 Common Stock View
RSLS 16 September, 2020 0001181166 4635 0001371217 STANKOVICH THOMAS A 4 530 Common Stock View
RSLS 16 September, 2020 0001601086 5312100 0001371217 ARMISTICE CAPITAL, LLC A 4 100 Common Stock View
RSLS 14 September, 2020 0001601086 1200000 0001371217 ARMISTICE CAPITAL, LLC A 4 1200000 Series G Warrants View
RSLS 20 August, 2020 0001601086 5312000 0001371217 ARMISTICE CAPITAL, LLC A 4 2000 Common Stock View
RSLS 19 August, 2020 0001181166 4105 0001371217 STANKOVICH THOMAS A 4 4105 Common Stock View
RSLS 19 August, 2020 0001601086 5310000 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 19 August, 2020 0001601086 5309000 0001371217 ARMISTICE CAPITAL, LLC A 4 998 Common Stock View
RSLS 18 August, 2020 0001601086 5308002 0001371217 ARMISTICE CAPITAL, LLC A 4 6000 Common Stock View
RSLS 17 July, 2020 0001601086 5302002 0001371217 ARMISTICE CAPITAL, LLC A 4 4500 Common Stock View
RSLS 13 April, 2020 0001601086 0 0001371217 ARMISTICE CAPITAL, LLC D 4 2516667 Series C Prefunded Warrants View
RSLS 13 April, 2020 0001601086 2728335 0001371217 ARMISTICE CAPITAL, LLC A 4 2516667 Common Stock View
RSLS 13 April, 2020 0001601086 5297502 0001371217 ARMISTICE CAPITAL, LLC A 4 2569167 Common Stock View
RSLS 25 March, 2020 0001601086 1200000 0001371217 ARMISTICE CAPITAL, LLC A 4 1200000 Series G Warrants View
RSLS 29 January, 2020 0001601086 211668 0001371217 ARMISTICE CAPITAL, LLC A 4 2000 Common Stock View
RSLS 29 January, 2020 0001601086 209668 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 20 December, 2019 0001601086 208668 0001371217 ARMISTICE CAPITAL, LLC A 4 3048 Common Stock View
RSLS 19 December, 2019 0001601086 205620 0001371217 ARMISTICE CAPITAL, LLC A 4 9000 Common Stock View
RSLS 16 December, 2019 0001601086 196620 0001371217 ARMISTICE CAPITAL, LLC A 4 3000 Common Stock View
RSLS 11 December, 2019 0001601086 193620 0001371217 ARMISTICE CAPITAL, LLC A 4 452 Common Stock View
RSLS 9 December, 2019 0001601086 193168 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 9 December, 2019 0001601086 192168 0001371217 ARMISTICE CAPITAL, LLC A 4 1071 Common Stock View
RSLS 6 December, 2019 0001601086 191097 0001371217 ARMISTICE CAPITAL, LLC A 4 300 Common Stock View
RSLS 5 December, 2019 0001601086 190797 0001371217 ARMISTICE CAPITAL, LLC A 4 224 Common Stock View
RSLS 5 December, 2019 0001601086 190573 0001371217 ARMISTICE CAPITAL, LLC A 4 1000 Common Stock View
RSLS 4 December, 2019 0001601086 189573 0001371217 ARMISTICE CAPITAL, LLC A 4 405 Common Stock View
RSLS 26 November, 2019 0001601086 189168 0001371217 ARMISTICE CAPITAL, LLC A 4 2000 Common Stock View
RSLS 22 November, 2019 0001601086 187168 0001371217 ARMISTICE CAPITAL, LLC A 4 1495 Common Stock View
RSLS 20 November, 2019 0001601086 185673 0001371217 ARMISTICE CAPITAL, LLC A 4 1300 Common Stock View
RSLS 18 November, 2019 0001601086 184373 0001371217 ARMISTICE CAPITAL, LLC A 4 205 Common Stock View
RSLS 18 November, 2019 0001601086 184168 0001371217 ARMISTICE CAPITAL, LLC A 4 1330 Common Stock View
RSLS 14 November, 2019 0001601086 182838 0001371217 ARMISTICE CAPITAL, LLC A 4 2200 Common Stock View
RSLS 12 November, 2019 0001601086 180638 0001371217 ARMISTICE CAPITAL, LLC A 4 636 Common Stock View
RSLS 11 November, 2019 0001601086 21600000 0001371217 ARMISTICE CAPITAL, LLC A 4 400000 Common Stock View
RSLS 23 September, 2019 0001601086 315000000 0001371217 ARMISTICE CAPITAL, LLC A 4 315000000 Series E Warrants View
RSLS 23 September, 2019 0001601086 308300000 0001371217 ARMISTICE CAPITAL, LLC A 4 308300000 Series F Prefunded Warrants View
RSLS 23 September, 2019 0001601086 0 0001371217 ARMISTICE CAPITAL, LLC D 4 315000000 Series B Warrants View
RSLS 23 September, 2019 0001601086 21200000 0001371217 ARMISTICE CAPITAL, LLC A 4 6700000 Common Stock View
RSLS 17 September, 2019 0001601086 14500000 0001371217 ARMISTICE CAPITAL, LLC A 4 396072 Common Stock View
RSLS 30 August, 2019 0001601086 14103928 0001371217 ARMISTICE CAPITAL, LLC A 4 28928 Common Stock View
RSLS 30 August, 2019 0001601086 14075000 0001371217 ARMISTICE CAPITAL, LLC A 4 25000 Common Stock View
RSLS 29 August, 2019 0001601086 14050000 0001371217 ARMISTICE CAPITAL, LLC A 4 45000 Common Stock View
RSLS 29 August, 2019 0001601086 14005000 0001371217 ARMISTICE CAPITAL, LLC A 4 25000 Common Stock View
RSLS 29 August, 2019 0001601086 13980000 0001371217 ARMISTICE CAPITAL, LLC A 4 10000 Common Stock View
RSLS 28 August, 2019 0001601086 13970000 0001371217 ARMISTICE CAPITAL, LLC A 4 50000 Common Stock View
RSLS 28 August, 2019 0001601086 13920000 0001371217 ARMISTICE CAPITAL, LLC A 4 50000 Common Stock View
RSLS 27 August, 2019 0001601086 13870000 0001371217 ARMISTICE CAPITAL, LLC A 4 10000 Common Stock View
RSLS 27 August, 2019 0001601086 13860000 0001371217 ARMISTICE CAPITAL, LLC A 4 10000 Common Stock View
RSLS 8 August, 2019 0001601086 13850000 0001371217 ARMISTICE CAPITAL, LLC A 4 100000 Common Stock View
RSLS 7 August, 2019 0001601086 13750000 0001371217 ARMISTICE CAPITAL, LLC A 4 250000 Common Stock View
RSLS 26 July, 2019 0001601086 13500000 0001371217 ARMISTICE CAPITAL, LLC A 4 300000 Common Stock View
RSLS 25 July, 2019 0001601086 13200000 0001371217 ARMISTICE CAPITAL, LLC A 4 150000 Common Stock View
RSLS 24 July, 2019 0001601086 13050000 0001371217 ARMISTICE CAPITAL, LLC A 4 50000 Common Stock View
RSLS 1 February, 2019 0001535610 1192000 0001371217 SABBY MANAGEMENT, LLC A 4 1192000 Series E Convertible Preferred Stock View
RSLS 1 February, 2019 0001535610 507 0001371217 SABBY MANAGEMENT, LLC D 4 1192000 Common Stock View
RSLS 31 January, 2019 0001535610 1192507 0001371217 SABBY MANAGEMENT, LLC A 4 10301 Common Stock View
RSLS 30 January, 2019 0001535610 1182206 0001371217 SABBY MANAGEMENT, LLC A 4 48000 Common Stock View
RSLS 29 January, 2019 0001535610 1134206 0001371217 SABBY MANAGEMENT, LLC A 4 12200 Common Stock View
RSLS 25 January, 2019 0001535610 1122006 0001371217 SABBY MANAGEMENT, LLC A 4 15595 Common Stock View
RSLS 24 January, 2019 0001535610 1106411 0001371217 SABBY MANAGEMENT, LLC A 4 6190 Common Stock View
RSLS 22 January, 2019 0001535610 1100221 0001371217 SABBY MANAGEMENT, LLC A 4 5766 Common Stock View
RSLS 18 January, 2019 0001535610 1094455 0001371217 SABBY MANAGEMENT, LLC A 4 24334 Common Stock View
RSLS 17 January, 2019 0001535610 1070121 0001371217 SABBY MANAGEMENT, LLC A 4 52 Common Stock View
RSLS 16 January, 2019 0001535610 1070069 0001371217 SABBY MANAGEMENT, LLC A 4 4700 Common Stock View
RSLS 16 January, 2019 0001535610 1065369 0001371217 SABBY MANAGEMENT, LLC A 4 21961 Common Stock View
RSLS 15 January, 2019 0001535610 1043408 0001371217 SABBY MANAGEMENT, LLC A 4 167760 Common Stock View
RSLS 18 April, 2018 0001224185 1161797 0001371217 YOUNGSTROM SCOTT P A 4 1161797 Stock Option (right to buy) View
RSLS 18 April, 2018 0001224184 4164281 0001371217 GLADNEY DAN W A 4 4164281 Stock Option (right to buy) View
RSLS 19 December, 2017 0001642607 26200 0001371217 Mashaal Michael Y D 4 20487 Series C Convertible Preferred Stock, $0.01 par value View
RSLS 19 December, 2017 0001642607 2617077 0001371217 Mashaal Michael Y A 4 2048700 Common Stock, $0.01 par value per share View
RSLS 19 December, 2017 0001538581 26200 0001371217 HealthCor Partners Fund II, L.P. D 4 20487 Series C Convertible Preferred Stock, par value $0.01 View
RSLS 19 December, 2017 0001538581 174472 0001371217 HealthCor Partners Fund II, L.P. A 4 136580 Common Stock, par value $0.01 per share View
RSLS 6 October, 2017 0001663861 145226 0001371217 Ansari Naqeeb A. A 4 145226 Stock Option (right to buy) View
RSLS 6 October, 2017 0001224185 284120 0001371217 YOUNGSTROM SCOTT P A 4 284120 Stock Option (right to buy) View
RSLS 6 October, 2017 0001224184 662975 0001371217 GLADNEY DAN W A 4 662975 Stock Option (right to buy) View
RSLS 25 May, 2017 0001110780 0 0001371217 GOLDFISCHER CARL A 4 4571 Common Stock View
RSLS 22 May, 2017 0001707234 29108.12 0001371217 Nihalani Rajesh A 4 29108.12 Non-voting Conditional Convertible Preferred Stock View
RSLS 22 May, 2017 0001707234 709099.8 0001371217 Nihalani Rajesh A 4 709099.8 Non-voting Conditional Convertible Preferred Stock View
RSLS 22 May, 2017 0001707234 978845 0001371217 Nihalani Rajesh A 4 978845 Common Stock, $0.01 par value per share View
RSLS 8 February, 2017 0001663861 93250 0001371217 Ansari Naqeeb A. A 4 93250 Stock Option (Right to Buy) View
RSLS 8 February, 2017 0001663746 93250 0001371217 DeLange Peter M. A 4 93250 Option (Right to Buy) View
RSLS 8 February, 2017 0001664114 93250 0001371217 Hickey Paul F. A 4 93250 Stock Option (Right to Bu) View
RSLS 8 February, 2017 0001224185 142200 0001371217 YOUNGSTROM SCOTT P A 4 142200 Stock Option (Right to Buy) View
RSLS 8 February, 2017 0001224184 466500 0001371217 GLADNEY DAN W A 4 466500 Stock Option (right to buy) View
RSLS 8 February, 2017 0001110780 35000 0001371217 GOLDFISCHER CARL A 4 35000 Director Option (Right to Buy) View
RSLS 8 February, 2017 0001156320 30000 0001371217 BLACKFORD GARY A 4 30000 Stock Option (Right to Buy) View
RSLS 8 February, 2017 0001200882 40000 0001371217 TETI NICHOLAS A 4 40000 Director Option (Right to Buy) View
RSLS 8 February, 2017 0001244288 35000 0001371217 GRIFFIN BOBBY IVAN A 4 35000 Director Option (Right to Buy) View
RSLS 8 February, 2017 0001454715 30000 0001371217 Tremmel Jon T A 4 35000 Director Option (Right to Buy) View
RSLS 8 February, 2017 0001649837 30000 0001371217 McDougal Lori Courtney A 4 30000 Director Option (Right to Buy) View
SymbolDatePeriodDownload XLSX File
RSLS 2020 FY Download XLSX File
RSLS 2019 FY Download XLSX File
RSLS 2018 FY Download XLSX File
RSLS 2017 FY Download XLSX File
RSLS 2016 FY Download XLSX File
RSLS 2015 FY Download XLSX File
RSLS 2013 FY Download XLSX File
RSLS 2021 Q1 Download XLSX File
RSLS 2020 Q4 Download XLSX File
RSLS 2020 Q3 Download XLSX File
RSLS 2020 Q2 Download XLSX File
RSLS 2020 Q1 Download XLSX File
RSLS 2019 Q4 Download XLSX File
RSLS 2019 Q3 Download XLSX File
RSLS 2019 Q2 Download XLSX File
RSLS 2019 Q1 Download XLSX File
RSLS 2018 Q4 Download XLSX File
RSLS 2018 Q2 Download XLSX File
RSLS 2018 Q1 Download XLSX File
RSLS 2017 Q4 Download XLSX File
RSLS 2017 Q3 Download XLSX File
RSLS 2017 Q2 Download XLSX File
RSLS 2017 Q1 Download XLSX File
RSLS 2016 Q4 Download XLSX File
RSLS 2016 Q3 Download XLSX File
RSLS 2016 Q2 Download XLSX File
RSLS 2016 Q1 Download XLSX File
RSLS 2015 Q4 Download XLSX File
RSLS 2015 Q3 Download XLSX File
RSLS 2015 Q2 Download XLSX File
RSLS 2015 Q1 Download XLSX File
RSLS 2014 Q4 Download XLSX File
RSLS 2014 Q2 Download XLSX File
RSLS 2014 Q1 Download XLSX File
RSLS 2013 Q4 Download XLSX File
RSLS 2013 Q3 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
18 May, 2021 RSLS -0.7 -0.7 amc 0 0
10 March, 2021 RSLS -1.23 -1.23 bmo 3207000 0
12 November, 2020 RSLS bmo 3602000 0
13 August, 2020 RSLS amc 1702000 0
16 May, 2019 RSLS bmo 3074000 0
14 November, 2018 RSLS amc 8000 0
14 August, 2018 RSLS -80640 -80640 amc 10000 0
14 May, 2018 RSLS -90720 -90720 amc 140000 0
2 April, 2018 RSLS -113400 -113400 amc 140000 0
14 November, 2017 RSLS -267120 -267120 amc 360000 0
8 August, 2017 RSLS -1911 -1911 bmo 90000 90000
16 May, 2017 RSLS -2667 -2667 bmo 40000 0
7 March, 2017 RSLS bmo 140000 0
10 November, 2016 RSLS -178.5 -178.5 bmo 300000 873529.41176471
4 August, 2016 RSLS -514.5 -514.5 bmo 280000 425714.28571429
5 May, 2016 RSLS -65.8 -65.8 bmo 70000 59574.468085106
17 February, 2016 RSLS -66.5 -66.5 bmo 150000 142105.26315789
9 November, 2015 RSLS -42 -42 bmo 60000 117000
6 August, 2015 RSLS -105 -105 bmo 80000 76800
30 April, 2015 RSLS -105 -105 bmo 0 0
18 February, 2015 RSLS -94.5 -94.5 bmo 0 0
12 November, 2014 RSLS -1.2 -1.2 bmo 0 0
7 August, 2014 RSLS -29106000 -29106000 bmo 0 0
30 April, 2014 RSLS -26460000 -26460000 bmo 0 0
12 February, 2014 RSLS -29106000 -29106000 bmo 0 0
31 October, 2013 RSLS -29106000 -29106000 bmo 0 0
31 July, 2013 RSLS -29106000 -29106000 bmo 0 0
1 May, 2013 RSLS -37044000 -37044000 bmo 0 0
13 February, 2013 RSLS -44982000 -44982000 bmo 311493 0
24 October, 2012 RSLS -37044000 -37044000 bmo 311493 0
7 August, 2012 RSLS -34398000 -34398000 bmo 190000 190000
24 April, 2012 RSLS -39690000 -39690000 bmo 120000 120000
26 January, 2012 RSLS -58212000 -58212000 bmo 0 0
20 October, 2011 RSLS -68796000 -68796000 bmo 0 0
21 July, 2011 RSLS -52920000 -52920000 bmo 0 0
25 April, 2011 RSLS -47628000 -47628000 bmo 0 0
27 January, 2011 RSLS -89964000 -89964000 bmo 0 0
21 October, 2010 RSLS -156114000 -156114000 bmo 0 0
22 July, 2010 RSLS -150822000 -150822000 bmo 0 0
21 April, 2010 RSLS -174636000 -174636000 bmo 0 0
28 January, 2010 RSLS -127008000 -127008000 bmo 0 0
23 October, 2009 RSLS -635040000 -635040000 bmo 0 0
23 July, 2009 RSLS -539784000 -539784000 bmo 0 0
23 April, 2009 RSLS -476280000 -476280000 bmo 0 0
29 January, 2009 RSLS -730296000 -730296000 bmo 0 0
21 October, 2008 RSLS -968436000 -968436000 bmo 0 0
24 July, 2008 RSLS -1079568000 -1079568000 bmo 0 0
23 April, 2008 RSLS -809676000 -809676000 bmo 0 0
20 February, 2008 RSLS -1746360000 -1746360000 bmo 0 0

Company Profile

Company Name ReShape Lifesciences Inc.
Symbol RSLS
Currency USD
Price 5.5
Exchange Name Nasdaq Capital Market (NASDAQ)
Industry Medical Devices
CEO Mr. Barton Bandy
Sector Healthcare
Country US
Full Time Employees 37
Phone 19494296680
Address 1001 Calle Amanecer
City San Clemente
State CALIFORNIA
Zip 92673
>